"This is the first year ExpreS[2]ion will participate in the annual J.P. Morgan Healthcare Conference and the associated Biotech Showcase. We are looking forward to introducing ExpreS[2]ion's pipeline and platform to a new global audience, obtaining inspiration from the world's leading healthcare companies, and expanding our network at the world's largest annual healthcare investment symposium," says CEO Bent Frandsen.

By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below and on the Company's website (https://expres2ionbio.com/meet-us-2/).

The J.P. Morgan Healthcare Conference is being held 9-12 January at The Westin St. Francis in San Francisco, California, USA. Both CEO Bent Frandsen and CFO Keith Alexander will participate and take meetings with potential partners and investors. Please contact your J.P. Morgan representative (https://www.jpmorgan.com/solutions/cib/insights/health-care-conference/) for information about how to attend the event.

The Biotech Showcase is being held 9-11 January at the Hilton San Francisco Union Square, also in San Francisco, California, USA. CEO Bent Frandsen will present the Company at 9:30 am PST on Wednesday January 11[th], 2023, at the event. Registration is possible via the Biotech Showcase website (https://informaconnect.com/biotech-showcase/).

Parties interested in taking a meeting with either Mr. Frandsen or Mr. Alexander at or around the event should reach out to CFO Keith Alexander directly via the contact details below.

Certified Adviser

Svensk Kapitalmarknadsgranskning AB